Analystreport

Zealand Pharma A/S (NASDAQ: ZEAL) had its price target lowered by analysts at Morgan Stanley from $45.00 to $44.00. They now have an "overweight" rating on the stoc

Zealand Pharma A/S - American Depositary Shares  (ZEAL) 
Last zealand pharma a/s - american depositary shares earnings: 11/15 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: zealandpharma.com